Discussion postHealthcare finance

DQ3 HP – Financing of Health Care

A process question wearing the clothes of a cost debate. How coverage decisions are actually made — evidence review, comparative effectiveness, and what Medicare is and is not allowed to weigh — is the part most posts skip.

Editorial process

Last reviewed · August 22, 2026

Written by

Maren Caldwell

MSN, RN, CNE

Medical-surgical nursing, pharmacology and NCLEX preparation

Reviewed by

Dr. Tessa Redmond

DNP, RN, CNE

Evidence-based practice and clinical education

On this page

Interpret the task
Assignment instructions
Deliverables
Proposed outline
Research plan
Reference shortlist
Final review

How a coverage decision is actually made

The brief hands you two cases and a process question, and the process half is what most posts leave out. Medicare coverage runs through national and local coverage determinations, with the statutory test being whether an item or service is reasonable and necessary; a national coverage analysis of the kind the Provenge review describes is that machinery running in public. What makes the example sharp is a constraint students rarely know about: Medicare is not permitted to make coverage decisions on cost grounds in the way several other national systems explicitly do, and the body created to fund comparative effectiveness research in the United States was barred from using cost-per-quality-adjusted-life-year thresholds. So the review had to be framed as a question about evidence rather than about price, while everyone involved understood the price was the issue. Say that plainly: a post treating the review as an ordinary argument about an expensive drug has missed what the article reports.

That gap is the ethical content, and naming it is better than a general appeal to fairness. Set out the competing claims plainly: a patient's claim on a treatment that extends life by a few months, a public payer's obligation to a whole beneficiary population from a fixed budget, a manufacturer's claim about the incentive to innovate, and a taxpayer's interest. Then use the second case, Medicaid expansion, to show the same tension at a different level, where a state's decision not to expand produces a coverage gap with measurable consequences for people just above and below a line, and where the decision was political rather than clinical. Close on the question the brief actually poses, which is whether cost containment and universal high-quality access can coexist. Take a position; the honest answers involve either explicit rationing rules or accepting the implicit rationing already in place.

Likely learning objectives

Describe how coverage determinations are made and on what statutory test.
Explain the constraint on using cost thresholds in United States coverage decisions.
Identify the competing ethical claims in a specific coverage dispute.
Take a position on whether cost containment and universal access can coexist.

Assignment instructions

Read the full question

Review every instruction before using the planning guidance that follows.

Assignment DQ3 HP – Financing of Health Care DQ3 HP – Financing of Health Care With coinciding concerns about health care costs and the imperative to improve quality of care, health care providers and others face difficult decisions in the effort to achieve an appropriate balance. Such decisions often are addressed in the policy arena. How do policymakers evaluate which health care services should be financed through government programs? How do ethics-related questions and other considerations play into this evaluation process? Is it possible to contain costs and provide accessible, high-quality care to all, or is the tension between cost and care inherent in the U.S. health care delivery system? These questions are central to health care financing decisions in the United States. For this Discussion, you will focus on the policy decision-making process that determines what types of care are covered by public and private insurers and the ethical aspects of such financial decisions. To prepare: Read the case study “Economic Impact of States Declining Medicaid Expansion” page 190 of the Milstead text( BOOK :HEALTH POLICY AND POLITIC ATTACHED BELLOW) . Review the information in the Washington Post article “Review of Prostate Cancer Drugs Provenge Renews Medical Cost-Benefit Debate” in the Learning Resources. ( DOCUMENT ATTACHED BELLOW) Consider how policy decisions currently are made about what will and will not be paid for and what changes, if any, could improve the process. Reflect on how the Washington Post example illustrates the tension between cost and care. Post your analysis and assessment of the ethical and economic challenges related to policy decisions such as those presented in the Washington Post article. How does this type of situation contribute to the tension between cost and care? Substantiate your response with at least two outside resources. CHECK THE MEDIA PRESENTATION ATTACHED BELLOW

Turn the brief into deliverables

01A description of the coverage decision process, not just its outcome.
02The reasonable-and-necessary standard and the limits on cost consideration.
03The competing claims of patient, payer, manufacturer and taxpayer.
04The Medicaid expansion case used as a second level of the same tension.
05A stated position on the cost-versus-care question.
06At least two outside sources.